Immediate Impact
116 standout
Citing Papers
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
2024 Standout
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Works of Denise Till being referenced
Inhalation devices for long-acting β2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD
2007
Inhaled Formoterol Dry Powder Versus Ipratropium Bromide in Chronic Obstructive Pulmonary Disease
2001
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Denise Till | 478 | 556 | 10 | 21 | 11 | 576 | |
| Moira H. Thomson | 453 | 526 | 11 | 21 | 9 | 573 | |
| Bettina Hederer | 426 | 585 | 9 | 19 | 8 | 613 | |
| John Kottakis | 560 | 626 | 26 | 19 | 19 | 658 | |
| Bernard E. Levine | 282 | 496 | 12 | 13 | 15 | 676 | |
| M. Reza Maleki-Yazdi | 439 | 541 | 3 | 7 | 17 | 574 | |
| Jacques P.H.M. Creemers | 434 | 467 | 14 | 21 | 16 | 612 | |
| Suzanne Marsh | 515 | 616 | 1 | 47 | 8 | 703 | |
| F. Di Perna | 387 | 455 | 16 | 28 | 21 | 517 | |
| Newhouse Mt | 194 | 445 | 24 | 11 | 12 | 548 | |
| Esther Sim | 271 | 416 | 33 | 9 | 525 |
All Works
Loading papers...